Digital Content 
NEWS #PharmaBuzz
29 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/european-commission-approves-blincyto-in-philadelphia-chromosome-negative-cd19-positive-b-cell-precursor-acute-lymphoblastic-leukemia-in-the-consolidation-phase-302363668.html
07 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blincyto-blinatumomab-added-to-chemotherapy-significantly-improves-survival-in-newly-diagnosed-pediatric-patients-with-b-cell-precursor-acute-lymphoblastic-leukemia-b-all-302325381.html
17 Jun 2024
// Lia DeGroot ENDPTS
https://endpts.com/amgen-nabs-new-blincyto-approval-for-certain-type-of-leukemia/
14 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-blincyto-blinatumomab-in-cd19-positive-philadelphia-chromosome-negative-b-cell-precursor-acute-lymphoblastic-leukemia-b-all-in-the-consolidation-phase-302173376.html
14 Jun 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557
08 Feb 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557
Share 